ScholarIQanswers from OpenAlex
Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis
PaperCitations, authors & open-access status
Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis have?
ScholarIQcitation count
Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis has 105 citations in the OpenAlex counts ScholarIQ stores.
When was Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis published?
ScholarIQyear
Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis has 2020 year in the ScholarIQ index.
What is the open-access status of Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis?
ScholarIQoa status
Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis has gold oa status in the ScholarIQ index.
What is the DOI of Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis?
ScholarIQdoi
The DOI for Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis is on the source record.
What is the PMID of Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis?
ScholarIQpmid
The PMID for Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis is on the source record.
What is the OpenAlex record for Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis?
ScholarIQopenalex
The OpenAlex for Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis is on the source record.